Anna Moszczynska, Ph.D. - Publications

2002 University of Toronto, Toronto, ON, Canada 
Neuroscience Biology

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ. Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug and Alcohol Dependence. 190: 20-28. PMID 29960919 DOI: 10.1016/J.Drugalcdep.2018.05.021  0.56
2016 Luong D, Kesharwani P, Killinger BA, Moszczynska A, Sarkar FH, Padhye S, Rishi AK, Iyer AK. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. Journal of Colloid and Interface Science. 484: 33-43. PMID 27585998 DOI: 10.1016/J.Jcis.2016.08.061  0.56
2016 Killinger BA, Moszczynska A. Characterization of α-Synuclein Multimer Stoichiometry in Complex Biological Samples by Electrophoresis. Analytical Chemistry. 88: 4071-84. PMID 26937787 DOI: 10.1021/Acs.Analchem.6B00419  0.56
2016 Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Do glutathione levels decline in aging human brain? Free Radical Biology & Medicine. PMID 26845616 DOI: 10.1016/J.Freeradbiomed.2016.01.029  0.56
2016 Killinger BA, Moszczynska A. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. Journal of Neurochemistry. 136: 510-25. PMID 26465779 DOI: 10.1111/Jnc.13391  0.56
2016 Moszczynska A. Methamphetamine Neurotoxicity and the Ubiquitin-Proteasome System Neuropathology of Drug Addictions and Substance Misuse. 2: 181-188. DOI: 10.1016/B978-0-12-800212-4.00017-0  0.56
2015 Moszczynska A, Flack A, Qiu P, Muotri AR, Killinger BA. Neurotoxic Methamphetamine Doses Increase LINE-1 Expression in the Neurogenic Zones of the Adult Rat Brain. Scientific Reports. 5: 14356. PMID 26463126 DOI: 10.1038/Srep14356  0.56
2015 Nadithe V, Liu R, Killinger BA, Movassaghian S, Kim NH, Moszczynska AB, Masters KS, Gellman SH, Merkel OM. Screening nylon-3 polymers, a new class of cationic amphiphiles, for siRNA delivery. Molecular Pharmaceutics. 12: 362-74. PMID 25437915 DOI: 10.1021/Mp5004724  0.56
2014 Chauhan H, Killinger BA, Miller CV, Moszczynska A. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum. International Journal of Molecular Sciences. 15: 5884-906. PMID 24717411 DOI: 10.3390/Ijms15045884  0.56
2014 Killinger B, Shah M, Moszczynska A. Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats. Journal of Neurochemistry. 128: 764-75. PMID 24151877 DOI: 10.1111/Jnc.12496  0.56
2013 Liu B, Traini R, Killinger B, Schneider B, Moszczynska A. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity. Experimental Neurology. 247: 359-72. PMID 23313192 DOI: 10.1016/J.Expneurol.2013.01.001  0.56
2013 Liu B, Killinger B, Moszczynska A. Overexpression of Parkin in The Nigrostriatal System Might Protect Dopaminergic Terminals From Methamphetamine Neurotoxicity Via Regulation of Dopamine Transporter Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 61. DOI: 10.1016/B978-0-12-800044-1.00055-6  0.56
2011 Moszczynska A, Yamamoto BK. Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. Journal of Neurochemistry. 116: 1005-17. PMID 21166679 DOI: 10.1111/J.1471-4159.2010.07147.X  0.56
2010 Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities: classical and emerging mechanisms. Annals of the New York Academy of Sciences. 1187: 101-21. PMID 20201848 DOI: 10.1111/J.1749-6632.2009.05141.X  0.56
2009 Moszczynska A, Locke SA, McLaughlin JD, Marcogliese DJ, Crease TJ. Development of primers for the mitochondrial cytochrome c oxidase I gene in digenetic trematodes (Platyhelminthes) illustrates the challenge of barcoding parasitic helminths. Molecular Ecology Resources. 9: 75-82. PMID 21564967 DOI: 10.1111/J.1755-0998.2009.02634.X  0.56
2008 Glass SK, Moszczynska A, Crease TJ. The effect of transposon Pokey insertions on sequence variation in the 28S rRNA gene of Daphnia pulex. Genome / National Research Council Canada = GéNome / Conseil National De Recherches Canada. 51: 988-1000. PMID 19088812 DOI: 10.1139/G08-092  0.56
2007 Moszczynska A, Saleh J, Zhang H, Vukusic B, Lee FJ, Liu F. Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity. Journal of Molecular Neuroscience : Mn. 32: 217-27. PMID 17873367 DOI: 10.1007/S12031-007-0037-0  0.56
2007 Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. The Embo Journal. 26: 2127-36. PMID 17380124 DOI: 10.1038/Sj.Emboj.7601656  0.56
2004 Pei L, Lee FJ, Moszczynska A, Vukusic B, Liu F. Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 1149-58. PMID 14762133 DOI: 10.1523/Jneurosci.3922-03.2004  0.56
2004 Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Why is parkinsonism not a feature of human methamphetamine users? Brain : a Journal of Neurology. 127: 363-70. PMID 14645148 DOI: 10.1093/Brain/Awh046  0.56
2002 Ross BM, Moszczynska A, Peretti FJ, Adams V, Schmunk GA, Kalasinsky KS, Ang L, Mamalias N, Turenne SD, Kish SJ. Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence. 67: 73-9. PMID 12062780 DOI: 10.1016/S0376-8716(02)00022-4  0.56
2001 Ross BM, Mamalias N, Moszczynska A, Rajput AH, Kish SJ. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience. 102: 899-904. PMID 11182251 DOI: 10.1016/S0306-4522(00)00501-7  0.56
2000 Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ. Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Molecular Psychiatry. 5: 664-72. PMID 11126397 DOI: 10.1038/Sj.Mp.4000760  0.56
2000 Ross BM, Eder K, Moszczynska A, Mamalias N, Lamarche J, Ang L, Pandolfo M, Rouleau G, Kirchgessner M, Kish SJ. Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 294-300. PMID 10752579 DOI: 10.1002/1531-8257(200003)15:2<294::Aid-Mds1013>3.0.Co;2-D  0.56
1999 Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research. 821: 407-13. PMID 10064828 DOI: 10.1016/S0006-8993(99)01123-3  0.56
1998 Moszczynska A, Turenne S, Kish SJ. Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neuroscience Letters. 255: 49-52. PMID 9839724 DOI: 10.1016/S0304-3940(98)00711-3  0.56
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease. Neuroscience. 83: 791-8. PMID 9483562 DOI: 10.1016/S0306-4522(97)00454-5  0.56
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. Journal of Neurochemistry. 70: 786-93. PMID 9453575 DOI: 10.1046/J.1471-4159.1998.70020786.X  0.56
1997 Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids. 32: 351-8. PMID 9113621 DOI: 10.1007/S11745-997-0044-X  0.56
1996 Ross BM, Moszczynska A, Kalasinsky K, Kish SJ. Phospholipase A2 activity is selectively decreased in the striatum of chronic cocaine users. Journal of Neurochemistry. 67: 2620-3. PMID 8931499 DOI: 10.1046/J.1471-4159.1996.67062620.X  0.56
1994 Zhou Y, Moszczynska A, Opas M. Generation and Characterization of Antibodies to Adhesion-related Molecules of Retinal Pigment Epithelial Cells Experimental Eye Research. 58: 585-594. PMID 7925696 DOI: 10.1006/Exer.1994.1053  0.56
1994 Moszczynska A, Opas M. Involvement of non-receptor protein tyrosine kinases in expression of differentiated phenotype by cells of retinal origin International Journal of Developmental Biology. 38: 1-12. PMID 7521198 DOI: 10.1387/Ijdb.7521198  0.56
1994 Moszczynska A, Opas M. Regulation of adhesion-related protein tyrosine kinases during in vitro differentiation of retinal pigment epithelial cells: translocation of pp60c-src to the nucleus is accompanied by downregulation of pp125FAK Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 72: 43-48. PMID 7520708 DOI: 10.1139/O94-007  0.56
Show low-probability matches.